Cambridge Nutritional Sciences PLC Omega Diagnostics court summons
21 Januar 2025 - 5:03PM
RNS Regulatory News
RNS Number : 1718U
Cambridge Nutritional Sciences PLC
21 January 2025
Cambridge Nutritional
Sciences plc
(the
'Company' or 'CNS')
Omega Diagnostics court
summons regarding alleged historical offences
Cambridge Nutritional Sciences plc
(AIM: CNSL), the specialist medical diagnostics company focused on
promoting a personalised and functional approach to health and
nutrition, has received a summons for its subsidiary Omega
Diagnostics in relation to an alleged historical breach of HSE
regulations. The alleged offences relate to
Omega South West, a company previously owned by Omega Diagnostics
Limited and sold in 2018.
The alleged historical breach
occurred in 2018 under legislation appertaining to the
possession and use of biological agents at a small
facility being used by Omega South West for
its trading activities during its existence. The facility in
question was sold in 2018 and in the same year Omega South
West ceased all trading activities. This
entity has not formed any part of the
Company's ongoing operations or business model and there are
currently no employees within the Company who had any dealings or
involvement with Omega South West.
The Company has received a
summons with a
first hearing scheduled for the 18th March 2025. The Company is discussing the matter
with its legal advisers and determining the best course of action
for all stakeholders.
The Company will make further announcements as appropriate.
Contacts:
Cambridge Nutritional Sciences plc
|
www.cnsplc.com
|
Carolyn Rand, Non-Executive
Chair
|
|
James Cooper, Interim Chief
Executive
|
|
|
|
Cavendish Capital Markets Limited
|
Tel: 020
7220 0500
|
Geoff Nash / Edward Whiley
(Corporate Finance)
|
|
Nigel Birks / Harriet Ward
(ECM)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc
(AIM: CNSL) is a specialist medical
diagnostics company focused on industry-leading Health and
Nutrition products.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
STRUARNRVUUAUAR
Cambridge Nutritional Sc... (LSE:CNSL)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Cambridge Nutritional Sc... (LSE:CNSL)
Historical Stock Chart
Von Jan 2024 bis Jan 2025